Transformative Pathology


The Transformative Pathology Program supports cancer research needs for high-quality tumour tissue, normal tissue, blood samples and their derivatives. It will coordinate the efforts of the Ontario Tumour Bank, the Ontario Cancer Biomarker Network and the Ontario Tumour Repository Network. The Program will provide a high quality collection and state-of-the-art storage infrastructure.

Transformative Pathology Program Fact Sheet

Download the Fact Sheet

Transformative Pathology Program Fact Sheet

Lead Principal Investigator

Dr. John Bartlett
Program Leader


New partnership brings Toronto researchers together to better understand the molecular origins of breast cancer (September 21, 2016)

New retrospective study aims to identify mutations to better diagnose breast cancer in the future (August 17, 2016)

Dr. John Bartlett interviewed by ecancertv
HER2 status as predictive marker for aromatase inhibitor versus tamoxifen use in early breast cancer (December 17, 2015)